Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 218-235-4 | CAS number: 2090-05-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1979-01-09 to 1979-02-13
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- Limited study summary, no GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 979
- Report date:
- 1979
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- This study used Swiss albino mice. In the range finding study, mice (10 males and 10 females) were administered 500, 1000, 2500, 5000 and 7500 mg/kg of test substance by oral gavage. In the main study, 30 male and 30 female mice, received 1500, 2000, 2500, 3000, 3500 and 4000 mg/kg of test substance. All the animals were closely observed until day 14 post-dosing for signs of acute intoxication and mortality.
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Benzoic acid
- EC Number:
- 200-618-2
- EC Name:
- Benzoic acid
- Cas Number:
- 65-85-0
- Molecular formula:
- C7H6O2
- IUPAC Name:
- Benzoic acid
- Test material form:
- not specified
- Details on test material:
- not specified
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- other: Swiss albino
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Bio Breeding Laboratories of Canada Ltd., Ottawa, Canada
- Age at study initiation: Approximately 30 days old
- Weight at study initiation: 18-22 grams
- Fasting period before study: 14-16 hours
- Housing: shoebox bins
- Diet (e.g. ad libitum): a pelleted diet (Purina Mouse Chow)
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 2 weeks
ENVIRONMENTAL CONDITIONS
- Temperature: 70-75 °F
- Humidity: 40-50 %
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: Tween-80
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 1.5%
- Amount of vehicle (if gavage): 20 mL/kg
- Justification for choice of vehicle: Due to its relative innocuous nature and ability to provide a stable homogeneous suspension.
- Doses:
- Range finding study: 500, 1000, 2500, 5000, 7500 mg/kg
Main study: 1500, 2000, 2500, 3000, 3500, 4000 mg/kg - No. of animals per sex per dose:
- Range finding study: 2 males and 2 females per dose
Main study: 5 males and 5 females per dose - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: twice daily
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight and histopathology - Statistics:
- From the accumulated mortality data the LD50 value and its 95% confidence limits were calculated according to the method of Litchfield and Wilcoxon, Journal of Pharmacology and Experimental Therapeutics, Vol. 96, 99-113, 1949.
Results and discussion
- Preliminary study:
- Within 24 hours and 14 days after administration, there was 100% mortality in the 2500 and 7500 mg/kg dose groups, and 50% mortality within the 5000 mg/kg dose group. No mortality was observed in the 500 mg/kg and 1000 mg/kg dose groups within 24 hours and 14 days. Animals surviving the 14-day observation period showed increased body weights. In no animal gross lesions were observed at necropsy.
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2 250 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 1 875 - <= 2 700
- Mortality:
- 24-hour mortality was 0, 30%, 70%, 50%, 80% and 100% for the respective dose groups. 14-day mortality was 0, 50%, 70%, 60%, 90% and 100% for the respective dose groups.
- Clinical signs:
- other: Signs of acute intoxication were absent in animals receiving 1500 mg/kg; however, in animals receiving 2000 mg/kg or greater, signs of acute intoxication consisted of decreased muscle tone, decreased activity and alertness as well as tonic convulsions and
- Gross pathology:
- All animals in both the range finding and definitive study were subjected to gross necropsy at the termination of the respenctive observation times. There was no lesions observed at necropsy in animals that had received 1500 mg/kg of the test substance; however, in animals that had received 2000 mg/kg or greater, there was evidence of gastric hemorrhage as demonstrated by the presence of coagulated blood in the stomach.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test substance produced signs of acute intoxication at doses greater than 2000 mg/kg.
According to the Regulation (EC) No 1272/2008 and subsequent adaptations, the substance is not acutely toxic via the oral route. - Executive summary:
This study used Swiss albino in the range finding study, mice ( 2/sex/dose) were administered 500, 1000, 2500, 5000 and 7500 mg/kg of test substance by oral gavage. In the main study mice (5/sex/dose) were exposed to 1500, 2000, 2500, 3000, 3500 and 4000 mg/kg of test substance. All the animals were closely observed until day 14 post-dosing for signs of acute intoxication and mortality.
The test substance produced signs of acute intoxication at doses greater than 2000 mg/kg. The LD50 was set at 2250 mg/kg bw
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
